LYNCH DANIEL

• Director at IMCLONE SYSTEMS INC/DE · on record since Mar 23, 2004
• Chief Executive Officer at IMCLONE SYSTEMS INC/DE · on record since Mar 23, 2004
• Director at BLUE HOLDINGS, INC. · on record since Jun 18, 2013
• Director at BIND Therapeutics, Inc · on record since Sep 27, 2013
• Director at Eleven Biotherapeutics, Inc. · on record since Feb 13, 2014
• Director at Blueprint Medicines Corp · on record since Apr 30, 2015
• Director at TRANSGENOMIC INC · on record since Jun 27, 2018
• Director at Surface Oncology, Inc. · on record since Apr 18, 2018
• Director at SOUTHWALL TECHNOLOGIES INC /DE/ · on record since Sep 16, 2019
• 10% owner at SOUTHWALL TECHNOLOGIES INC /DE/ · on record since May 22, 2020
• Director at Omega Alpha SPAC · on record since Jan 6, 2021
• Director at Xilio Therapeutics, Inc. · on record since Oct 21, 2021
• 10% owner at Xilio Therapeutics, Inc. · on record since Oct 21, 2021
• Director at 2seventy bio, Inc. · on record since Oct 18, 2021